author-photo

Andrew K. Cheng

59

Papers

7541

Citations

Citation Trend

Filter By

Papers (45) Sort By

Journal Conference Others

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults.

2017 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (40)
Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial

2017 The Lancet HIV
Show All
- Source
- Cite
- Save
Citations (55)
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment

2017 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (49)
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

2016 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (209)
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide

2016 EBioMedicine
Show All
- Source
- Cite
- Save
Citations (10)
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results.

2016 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (138)
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

2016 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (153)
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected Adults.

2016 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (44)
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study.

2015 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (113)
Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients

2014 Hiv Clinical Trials
Show All
- Source
- Cite
- Save
Citations (23)